Abstract
Background
Although research has demonstrated the detrimental effects of excessive negative affect on treatment adherence and morbidity in chronic illness, rarely have researchers investigated the benefits of awareness of negative emotional experiences during treatment.
Purpose
In this investigation, we examined the association of negative affect differentiation (the ability to report negative emotional experiences as separate and distinct from each other,) to treatment adherence in adult patients with the congenital blood disorder thalassemia.
Method
Negative affect differentiation was assessed during a 12–16-week treatment-based diary and adherence was operationalized as attendance at routine screenings over 12 months. Participants were adult patients (n = 32; age M = 31.63, SD = 7.72; 72 % female) with transfusion-dependent thalassemia in treatment in a large metropolitan hospital in the Northeastern USA.
Results
The results indicate that negative affect differentiation is significantly associated with greater adherence to treatment, even when controlling for disease burden and level of psychological distress.
Conclusion
Although preliminary, this investigation suggests that differentiated processing of negative emotional experiences during illness can lead to adaptive treatment-related behavior. As such, it may present a new avenue for research and intervention targeting the improvement of adherence during treatment for chronic illness.
Similar content being viewed by others
Notes
This includes patients with β-thalassemia major, β-thalassemia intermedia, and Diamond–Blackfan anemia, an erythroid hypoplasia.
Two participants did not complete the diary correctly, one participant moved prior to the end of the diary, and three participants completed less than six diary entries. There were no significant demographic or disease-related differences between those individuals included in this investigation and those recruited for the larger study.
We also initially considered including age and educational attainment as controls because prior evidence has suggested developmental factors can influence affective processing [70]. However, these variables had no meaningful effect on the results and were dropped.
References
Rund DR, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353:1135–46.
Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005;1054:18–24.
Borgna-pignatti C, Rugolotto S, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89:1187–93.
Borgna-Pignatti C, Cappellini MD, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054:40–7.
Rachmilewitz EA, Giardina PJ. How I treat thalassemia. Blood. 2011;118:3479–88.
Taher AT, Musallam KM, et al. Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010;115:1886–92.
Neufeld EJ. Oral chelators deferasiroz and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood. 2006;107:3436–41.
Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR. Complications of B-thalassemia major in North America. Blood. 2004;104:34–9.
Bazrgar M, Peiravian F, Apedpour F, Karimi M. Causes for hospitalization and death in Iranian patients with B-thalassemia major. Pediatr Hematol Oncol. 2011;28:134–9.
Cakaloz B, Cakaloz I, Polat A, Inan M, Oguzhanoglu NK. Psychopathology in thalassemia major. Pediatr Int. 2009;51:825–8.
Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, et al. Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort. Am J Hematol. 2010;10:802–5.
Messina G, Colombo E, Cassinerio E, Ferri F, Curti R, Altamura C, et al. Psychosocial aspects and psychiatric disorders in young adults with thalassemia major. Intern Emerg Med. 2008;3:339–43.
Evangeli MM, Mughal K, Porter JB. Which psychosocial factors are related to chelation adherence in thalassemia? A systematic review. Hemoglobin. 2010;34:305–21.
Treadwell MJ, Weissman L. Improving adherence with dereroxamine regimens for patients receiving chronic transfusion therapy. Semin Hematol. 2001;38:77–84.
Trachtenberg F, Vichinsky E, et al. Iron chelation adherence to deferoxamine and deferasirox in thalassemia. Am J Hematol. 2011;86:433–6.
Koch DA, Giardina PJ, Ryan M, MacQueen M, Hilgartner MW. Behavioral contracting to improve adherence in patients with thalassemia. J Pediatr Nurs. 1993;8:106–11.
Delea TE, Edelsberg J, et al. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion. 2007;47:1919–29.
Porter JB, Evangeli M, El-Beshlawy A. The challenges of adherence and persistence with iron chelation therapy. Int J Hematol. 2011;94:453–60.
Modell B, Khan M, Darlison M. Survival in B-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000;355:2051–2.
Kolnagou A, Kontoghiorghes GJ. Advances in the prevention and treatment are changing thalassemia from a fatal to a chronic disease. Experience from a Cyprus model and its use as a paradigm for future applications. Hemoglobin. 2007;33:287–95.
Eakin EG, Youlden DR, et al. Health behaviors of cancer survivors: data from an Australian population-based survey. Cancer Causes Control. 2007;18:881–94.
Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: a new challenge in delivering quality cancer care. J Clin Oncol. 2006;24:5101–4.
Pinto BM, Trunzo JJ. Health behaviors during and after a cancer diagnosis. Cancer. 2005;104:2614–23.
Robinson JD, Turner JW, Levine B, Tian Y. Patient–provider interaction and the regulation of diabetes mellitus. Heal Commun. 2010;25:597–8.
Bell RA, Andres JS, et al. Depressive symptoms and diabetes self-management among rural older adults. Am J Heal Behav. 2010;34:36–44.
Bennett P. How can we reduce the distress associated with health screening? From psychological theory to clinical practice. Soc Personal Compass. 2009;3(6):939–48.
Absetz P, Aro AR, Sutton SR. Experience with breast cancer, prescreening perceived susceptibility and the psychological impact of screening. Psycho-Oncology. 2003;12:305–18.
Watson M, Foster C, et al. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer. 2004;91:1787–94.
Ong G, Austocker J, Brett J. Breast screening: adverse psychological consequences one month after placing women on early recall because of diagnostic uncertainty. A multi-centre study. J Med Screen. 1997;4:158–68.
Moussavi S, Chatteriji S, Verdes E, Tandon A, Vikram P, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–8.
Kalsekar ID, Madhavan SS, Amonkar MM, Makela EH, Scott VG, Douglas SM, et al. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents. Ann Pharmacother. 2006;40:605–11.
Swendeman D, Ingram BL, Rotheram-Borus MJ. Common elements in self-management of HIV and other chronic illnesses: an integrative framework. AIDS Care. 2009;10(10):1321–34.
Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2009;25:1209–21.
Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social-support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Heal Psychol. 2006;25(1):74–81.
van Servellen G, Chang B, Garcia L, Lombardi E. Individual and system level factors associated with treatment nonadherence in human immunodeficiency virus-infected men and women. AIDS Patient Care STDS. 2002;16(6):269–81.
Consedine NS. Health-promoting and health-damaging effects of emotions. In: Lewis JMH-J, Barrett LF, editors. Handbook of emotions. 3rd ed. New York: Guilford; 2008.
Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84:191–215.
Leventhal H, Leventhal EA, Contrada RJ. Self-regulation, health, and behavior: a perceptual–cognitive approach. Psychol Heal. 1998;13:717–33.
Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–2011.
Lazarus RS, Folkman S. Stress, appraisal, and coping. New York: Springer; 1984.
Lindquist KA, Barrett LF. Emotional complexity. In: Lewis M, Haviland-Jones JM, Barrett LF, editors. Handbook of emotions. 3rd ed. New York: Guilford; 2008. p. 513–32.
Coifman KG, Bonanno GA. Emotion-context sensitivity in adaptation and recovery. Emotion regulation in psychopathology. New York: Guilford; 2009.
Ekman P. An argument for basic emotions. Cogn Emot. 1992;6:169–200.
Gray JA. The neuropsychology of anxiety. New York: Oxford University Press; 1982.
Affleck G, Tennen H, Zautra A, Urrows S, Abeles M, Karoly P. Women’s pursuit of personal goals in daily life with fibromyalgia: a value-expectancy analysis. J Consult Clin Psychol. 2001;69:587–96.
Gohm CL, Clore GL. Individual differences in emotion experience: mapping available scales to processes. Personal Soc Psychol Bull. 2000;26:679–97.
Barrett LF, Gross J, Christensen TC, Benvenuto M. Knowing what you’re feeling and knowing what to do about it: mapping the relation between emotion differentiation and emotion regulation. Cogn Emot. 2001;15(6):713–24.
Gross JJ. Handbook of emotion regulation. New York: Guilford; 2007.
Hill-Briggs F. Problem solving in diabetes self-management: a model of chronic illness self-management behavior. Ann Behav Med. 2003;25(3):182–93.
Pond RS, Kashdan TB, DeWall CN, Savostyanova A, Lambert NM, Fincham FD. Emotion differentiation moderates aggressive tendencies in angry people: a daily diary analysis. Emotion. 2012;12(2):326–37.
Kashdan TB, Ferssizidis P, Collins RL, Muraven M. Emotion differentiation as resilience against excessive alcohol use: an ecological momentary assessment in underage social drinkers. Psychol Sci. 2010;21(9):1341–7.
Tugade MM, Fredrickson BL, Barrett LF. Psychological resilience and positive emotional granularity: examining the benefits of positive emotions on coping and health. J Personal. 2004;72(6):1161–90.
Barrett LF. Solving the emotion paradox: categorization and the experience of emotion. Personal Soc Psychol Rev. 2006;10:20–46.
Mayer JD, Caruso D, Salovey P. Emotional intelligence meets traditional standards for an intelligence. Intelligence. 2000;27(4):267–98.
Mayer JD, Salovey P, Caruso DR. Emotional intelligence: theory, findings, and implications. Psychol Inq. 2004;60:197–215.
Russell JA. Culture and the categorization of emotion. Psychol Bull. 1991;110:426–50.
Denham SA. Social cognition, prosocial behavior, and emotion in preschoolers: contextual validation. Child Dev. 1986;57:194–201.
Dunsmore JC, Kam MA. The influence of peer relationships and maternal socialization on kindergartners’ developing emotion knowledge. Early Educ Dev. 2004;15:39–56.
Hall CLM, Updegraff JA. Mindfulness and its relationship to emotional regulation. Emotion. 2012;12(1):81–90.
Zaki LF, Coifman KG, Rafaeli E, Berenson K, Downey G. Emotion differentiation as a protective factor against nonsuicidal self-injury in borderline personality disorder. 2012.
Bolger N, Davis A, Rafaeli E. Diary methods: capturing life as it is lived. Annu Rev Psychol. 2003;54:579–616.
Holroyd KA, Labus JS, Carlson B. Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: the role of disorder severity and psychiatric comorbidity. Pain. 2009;143(3):213–22.
Sales AE, Tipton EF, Levine DA, Houston TK, Kim Y, Allison J, et al. Are co-morbidities associated with guideline adherence? The MI-Plus study of Medicare patients. J Gen Intern Med. 2009;24(11):1205–10.
Coifman KG, Kleinert D, Ross GS, Giardina P. Psychological coping in adult patients with thalassemia. Ninth Annual Cooley’s Anemia Symposium; New York, NY; 2009.
Coifman KG, Bonanno GA, Rafaeli E. Affect dynamics, bereavement and resilience to loss. J Happiness Stud. 2007;8:371–92.
Coifman KG, Bonanno GA. When distress does not become depression; emotion context sensitivity and adjustment to bereavement. J Abnorm Psychol. 2010;119:479–90.
Rafaeli E, Rogers GM, Revelle W. Affective synchrony: individual differences in mixed emotions. Personal Soc Psychol Bull. 2007;33:915–32.
Russell JA. A circumplex model of affect. J Personal Soc Psychol. 1980;39:1161–78.
Derogatis LR. SCL-90-R administration, scoring and procedures manual-II for the R (revised) version. Towson: Clinical Psychometric Research; 1983.
Carstenson LL. The influence of a sense of time on human development. Science. 2006;312(5782):1913–5.
Ayduk OK, Kross E. From a distance: implications of spontaneous self-distancing for adaptive self-regulation. J Personal Soc Psychol. 2010;98(5):809–29.
Nolen-Hoeksema S, Wisco BE, Lyubomirsky S. Rethinking rumination. Perspect Psychol Sci. 2008;3(5):400–25.
Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288(19):2469–75.
Beck JS. Cognitive behavioral therapy, second edition, basics and beyond. New York: Guilford; 2011.
Ganzella M, Zago MMF. The experience of thalassemic adults with their treatment. Lat Am J Nurs. 2011;19:968–76.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coifman, K.G., Ross, G.S., Kleinert, D. et al. Negative Affect Differentiation and Adherence During Treatment for Thalassemia. Int.J. Behav. Med. 21, 160–168 (2014). https://doi.org/10.1007/s12529-012-9277-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12529-012-9277-7